You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cisplatin-resistant

Showing 1 - 25 of 7,915
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Testicular Cancer Trial in Worldwide (cabazitaxel)

Recruiting
  • Testicular Cancer
  • Copenhagen, Denmark
  • +4 more
Jul 18, 2022

Prostate Cancer Trial in Rochester (Cisplatin)

Recruiting
  • Prostate Cancer
  • Rochester, New York
    Wilmot Cancer Institute
Jun 7, 2022

Ovarian Cancer Trial in Los Angeles (Pembrolizumab, Gemcitabine, Cisplatin)

Completed
Has Results
  • Ovarian Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 14, 2022

Tumors, Germ Cell and Embryonal Trial in Meldola, Napoli (Olaparib)

Unknown status
  • Neoplasms, Germ Cell and Embryonal
  • Meldola, FC, Italy
  • +1 more
Feb 25, 2021

Germ Cell Tumors, Measurable Disease Trial in Milano (Pazopanib)

Completed
  • Germ Cell Tumors
  • Measurable Disease
  • Milano, Mi, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021

Head Neck Cancer Trial in Jerusalem (TumoCure)

Not yet recruiting
  • Head and Neck Cancer
  • TumoCure
  • Jerusalem, Israel
    Hadassah Medical Center
Jan 23, 2022

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

Terminated
  • Advanced Solid Tumor
  • +3 more
  • Darlinghurst, New South Wales, Australia
  • +1 more
Dec 18, 2022

Anal Canal Carcinoma Trial in France (Docetaxel, Cisplatin and 5-Fluorouracil)

Completed
  • Anal Canal Carcinoma
  • Docetaxel, Cisplatin and 5-Fluorouracil
  • Besançon, France
  • +15 more
May 10, 2022

Small Cell Carcinoma, NSCLC, Neuroendocrine Tumors Trial in United States (RRx-001, Cisplatin, Etoposide)

Active, not recruiting
  • Small Cell Carcinoma
  • +3 more
  • Palo Alto, California
  • +9 more
May 12, 2022

Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III

Terminated
  • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +9 more
  • Bintrafusp Alfa
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)

Recruiting
  • Ototoxicity, Drug-Induced
  • Sodium Thiosulfate
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 6, 2023

Esophageal Squamous Cell Carcinoma Trial in Nanjing (Carrelizumab, Paclitaxel injection, Cisplatin)

Enrolling by invitation
  • Esophageal Squamous Cell Carcinoma
  • Nanjing, China
    The First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023

Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma

Recruiting
  • Bladder Small Cell Neuroendocrine Carcinoma
  • +16 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022

Nasopharyngeal Carcinoma Trial in Shanghai (Anti-EGFR and PD-1 inhibitor arm)

Recruiting
  • Nasopharyngeal Carcinoma
  • Anti-EGFR and PD-1 inhibitor arm
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Nov 26, 2023

Ovarian Epithelial Cancer Recurrent, Platinum-resistant Trial in Rome (Pressurized intraperitoneal aerosol chemo with cisplatin

Unknown status
  • Ovarian Epithelial Cancer Recurrent
  • Platinum-resistant
  • Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin
  • Rome, Italy
    Catholic University of Sacred Heart
Mar 6, 2020

Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Homologous Recombination Deficiency
  • (no location specified)
Oct 18, 2023

Oesophageal Carcinoma Trial in Australia (APR-246)

Terminated
  • Oesophageal Carcinoma
  • Clayton, Victoria, Australia
  • +4 more
Dec 10, 2021

ERCC1 and OCT2 on Occurrence and Severity of Cisplatin-induced

Not yet recruiting
  • Cisplatin Adverse Reaction
  • ERCC1
  • OCT2
  • Cairo, Egypt
    Faculty of medicine, Ain Shams University
Feb 9, 2022

Gastric Adenocarcinoma, Gastric Cancer Trial in Odense, Stockholm (Doxorubicin, Cisplatin)

Completed
  • Gastric Adenocarcinoma
  • Gastric Cancer
  • Odense, Denmark
  • +1 more
Oct 5, 2022

Gestational Trophoblastic Tumors Trial in Hangzhou (Etoposide, actinomycin D, methotrexate)

Recruiting
  • Gestational Trophoblastic Neoplasms
  • Hangzhou, Zhejiang, China
    Weiguo Lv
Jun 2, 2022

Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

Recruiting
  • Solid Tumor
  • +11 more
  • TRK-950
  • +14 more
  • Scottsdale, Arizona
  • +13 more
Oct 2, 2022

Cholangiocarcinoma Trial in Worldwide (Fimaporfin and Gemcitabine, Gemcitabine/Cisplatin chemo)

Active, not recruiting
  • Cholangiocarcinoma
  • Fimaporfin and Gemcitabine
  • Gemcitabine/Cisplatin chemotherapy
  • Duarte, California
  • +49 more
Mar 4, 2022

NSCLC Trial in Worldwide (pembrolizumab, pemetrexed, carboplatin)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • pembrolizumab
  • +4 more
  • Los Angeles, California
  • +157 more
Aug 18, 2022

Recurrent Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in United States (ChemoID Assay, Standard Chemotherapy)

Recruiting
  • Recurrent Ovarian Carcinoma
  • Platinum-resistant Ovarian Cancer
  • ChemoID Assay
  • Standard Chemotherapy
  • Phoenix, Arizona
  • +9 more
Oct 16, 2021